Company intelligence / Profile preview

Cathetrix

Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

Cathetrix develops and commercializes the Foley-Safe 2.0, a catheter securement device with FDA and CE Mark clearances that prevents accidental Foley catheter extractions and reduces CAUTI risk by stabilizing the catheter and deflating the balloon upon excessive pull force.

Therapeutic areas: NephrologyInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

TAEL ConsultingJenko

Beyond the preview

Go deeper on Cathetrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathetrix.

Explore the full profile